TUMOUR CAVITATION

TUMOUR CAVITATION was reported 55 times

TUMOUR CAVITATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RAMUCIRUMAB 9 0.0014
1 NALDEMEDINE 1 0.0006
2 REGORAFENIB 5 0.0004
3 LEMBOREXANT 1 0.0003
4 AMIVANTAMAB-VMJW 1 0.0003
5 VONOPRAZAN FUMARATE 2 0.0002
6 PACLITAXEL 16 0.0002
7 AFATINIB 1 0.0002
8 PAZOPANIB HYDROCHLORIDE 4 0.0001
9 ENFORTUMAB VEDOTIN 1 0.0001
10 CARBOPLATIN 16 0.0001
11 EVEROLIMUS TABLETS 2 0.0001
12 DOCETAXEL ANHYDROUS 7 0.0001
13 DOCETAXEL 7 0.0001
14 SORAFENIB 2 0.0001
15 BEVACIZUMAB 11 0.0001
16 PEGFILGRASTIM 1 0.0001
17 SUVOREXANT 1 0.0001
18 IPILIMUMAB 3 0.0001
19 NIVOLUMAB 6 0.0001
20 PEMETREXED DISODIUM 2 0.0001
21 MAGNESIUM OXIDE 2 0.0000
22 CABOZANTINIB 2 0.0000
23 ETOPOSIDE 3 0.0000
24 EVEROLIMUS 2 0.0000
25 GEMCITABINE HYDROCHLORIDE 2 0.0000
26 DOXORUBICIN 3 0.0000
27 TRAMADOL HYDROCHLORIDE 1 0.0000
28 CYCLOPHOSPHAMIDE FOR INJECTION 3 0.0000
29 CYCLOPHOSPHAMIDE 3 0.0000
30 OXALIPLATIN 1 0.0000
31 FLUOROURACIL CREAM, 0.5% 1 0.0000
32 FLUOROURACIL 1 0.0000
33 CISPLATIN 1 0.0000
34 MORPHINE SULFATE 1 0.0000
35 LORAZEPAM 1 0.0000
36 ESOMEPRAZOLE MAGNESIUM 1 0.0000
37 PREGABALIN 1 0.0000
38 METHOTREXATE SODIUM 1 0.0000
39 ADALIMUMAB 1 0.0000